San Diego, CA, United States of America

Xu Meng

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Xu Meng: Innovator in Oral Formulations

Introduction

Xu Meng is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on oral administration methods. With a total of six patents to his name, Xu has established himself as a key figure in the development of innovative drug delivery systems.

Latest Patents

Among his latest patents, Xu Meng has developed oral formulations and lipophilic salts of methylnaltrexone. This invention provides compositions comprising methylnaltrexone or a salt thereof, along with various formulations for effective oral administration. His work in this area aims to enhance the bioavailability and therapeutic efficacy of methylnaltrexone, a medication used to treat opioid-induced constipation.

Career Highlights

Xu Meng is currently employed at Wyeth, a well-known pharmaceutical company. His role involves extensive research and development in the area of drug formulations. His innovative approach has led to advancements that benefit patients requiring effective treatment options.

Collaborations

Throughout his career, Xu has collaborated with notable colleagues, including Syed Muzafar Shah and Christopher Richard Diorio. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Xu Meng's contributions to oral formulations and his innovative patents reflect his dedication to improving drug delivery systems. His work continues to impact the pharmaceutical industry positively, paving the way for more effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…